fluorodeoxyglucose f18 has been researched along with Depressive Disorder, Treatment-Resistant in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Baeken, C; De Raedt, R; Wu, GR | 1 |
Baeken, C; De Raedt, R; Van Schuerbeek, P; Wu, GR | 1 |
Brutsche, N; Carlson, PJ; Diazgranados, N; Drevets, WC; Herscovitch, P; Ibrahim, L; Luckenbaugh, DA; Manji, HK; Nugent, AC; Zarate, CA | 1 |
Ameli, R; Lally, N; Luckenbaugh, DA; Nugent, AC; Roiser, JP; Zarate, CA | 1 |
Bewernick, BH; Hurlemann, R; Kayser, S; Matusch, A; Schlaepfer, TE; Soehle, M | 1 |
Baeken, C; Wu, GR | 1 |
Chen, MH; Hong, CJ; Li, CT; Lin, WC; Liu, RS; Su, TP; Tu, PC; Yang, BH | 1 |
Bucholz, RD; Chibnall, JT; Christensen, JJ; Conway, CR; Gangwani, S; Giuffra, LA; Hershey, T; Mintun, MA; Price, JL; Sheline, YI | 1 |
4 trial(s) available for fluorodeoxyglucose f18 and Depressive Disorder, Treatment-Resistant
Article | Year |
---|---|
Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.
Topics: Adult; Antidepressive Agents; Brain; Brain Mapping; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Ketamine; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen; Positron-Emission Tomography | 2013 |
Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.
Topics: Adolescent; Adult; Aged; Anhedonia; Bipolar Disorder; Brain; Cross-Over Studies; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Humans; Ketamine; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome; Young Adult | 2014 |
Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects.
Topics: Adult; Anxiety; Brain; Convulsive Therapy; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Magnetic Field Therapy; Male; Middle Aged; Positron-Emission Tomography; Quality of Life; Radiopharmaceuticals; Recurrence; Treatment Outcome | 2015 |
The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.
Topics: Adult; Amygdala; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Glutamic Acid; Humans; Ketamine; Linear Models; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Psychiatric Status Rating Scales; Radiopharmaceuticals | 2016 |
4 other study(ies) available for fluorodeoxyglucose f18 and Depressive Disorder, Treatment-Resistant
Article | Year |
---|---|
Dorsomedial frontal cortical metabolic differences of comorbid generalized anxiety disorder in refractory major depression: A [
Topics: Adult; Anxiety Disorders; Comorbidity; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Opposite subgenual cingulate cortical functional connectivity and metabolic activity patterns in refractory melancholic major depression.
Topics: Adult; Brain; Brain Mapping; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Temporal Lobe; Transcranial Magnetic Stimulation | 2020 |
Longer depressive episode duration negatively influences HF-rTMS treatment response: a cerebellar metabolic deficiency?
Topics: Adult; Brain; Brain Mapping; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Transcranial Magnetic Stimulation; Treatment Outcome | 2017 |
Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?
Topics: Adult; Cerebral Cortex; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Vagus Nerve Stimulation | 2012 |